Abstract
Transmembrane α-Klotho (TM-Klotho), expressed in renal tubules, is a cofactor for FGF23-receptor. Circulating soluble-α-Klotho (s-Klotho) results from TM-Klotho shedding and acts on Phosphate (P) and Calcium (Ca) tubular transport. Decreased TM-Klotho, described in experimental chronic kidney disease (CKD), prevents actions of FGF23 and lessens circulating s-Klotho. Thus, levels of s-Klotho could represent a marker of CKD-MBD. To evaluate the clinical significance of s-Klotho in CKD we assayed serum s-Klotho and serum FGF23 in 68 patients (age 58±15; eGFR 45±21 mL/min). s-Klotho was lower than normal (519±183 versus 845±330 pg/mL, P
Cite
CITATION STYLE
Rotondi, S., Pasquali, M., Tartaglione, L., Muci, M. L., Mandanici, G., Leonangeli, C., … Mazzaferro, S. (2015). Soluble α -Klotho serum levels in chronic kidney disease. International Journal of Endocrinology, 2015. https://doi.org/10.1155/2015/872193
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.